The largest database of trusted experimental protocols

21 protocols using anti mir con

1

miR-128-3p Transfection in Melanoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
The agomir and antagomir for miR-128-3p (pre-miR-128-3p and anti-miR-128-3p) as well as their negative control (pre-miR-con and anti-miR-con) were obtained from GenePharma (Shanghai, China). Lipofectamine 3000 (Invitrogen, Foster City, CA, USA) was applied to transfect miRNAs into A375 and M14 cells according to manufacturers’ protocols. The transfected efficiency was evaluated with use of qRT-PCR, with 48 h after transfection being the best time point for subsequent examinations.
+ Open protocol
+ Expand
2

Modulating miR-15b Expression Using Mimics and Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
miR-15b mimics, miRNA mimic negative control (miRcon), miR-15b inhibitors (anti-miR-15b), and miRNA inhibitor negative control (anti-miR-con) were purchased from GenePharma (Shanghai, China). Synthetic miR-15b mimics, miR-con, miR-15b inhibitors, and anti-miR-con were transfected into cells using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. Small interfering RNA (siRNA) vectors targeting BACE1 were purchased from GenePharma (Shanghai, China). Transfection was conducted using Lipofectamine 2000 (Invitrogen) according to manufacturer’s instructions.
+ Open protocol
+ Expand
3

Overexpression of Flot2 and miR-802 Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Overexpression Flot2 plasmid pcDNA3.1-Flot2, miR-802 mimics, miR-802 inhibitor and their control miRNA oligonucleotides (miR-Con, anti-miR-Con) were acquired from GenePharm (Shanghai, China) and transfected into the cells with Lipofectamine™ 2000 transfection reagent (Invitrogen) according to the manufacturer’s instructions. In cell transfection, cells were seeded in six-well plates and cultured until 50–70% confluency was reached in 1 day.
+ Open protocol
+ Expand
4

Targeting UCA1 lncRNA in Renal Cell Carcinoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNAs targeting UCA1 (siUCA1-1) and siUCA-2 and its scrambled control (siCon), miR129 mimic and its scrambled control (miR-Con), miR129 inhibitor (anti-miR129), and anti-miR-Con were purchased from GenePharma (Shanghai, China). Full-length sequences of UCA1 were amplified by polymerase chain reaction (PCR) and inserted into pcDNA3.1 vector (Thermo Fisher Scientific) to gain the UCA1-overexpression plasmid. All oligonucleotides or plasmids were transfected into RCC cells using Lipofectamine 2000 reagent (Thermo Fisher Scientific) according to the manufacturer’s instructions. The target sequences of siUCA1 were siUCA1-1 (5′-GGACAACAGTACACGCATA-3′) and siUCA1-2 (5′-TCTTTGTCTCCTGGATTAAC-3′).
+ Open protocol
+ Expand
5

Investigating XIST and miR-29c in NPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNAs against XIST (si-XIST-1, si-XIST-2), siRNA control (si-con), pcDNA-XIST, pcDNA empty vector (vector), miR-29c mimic (miR-29c), miRNA control (miR-con), miR-29c inhibitor (anti-miR-29c), and control inhibitor (anti-miR-con) were purchased from GenePharma Co., Ltd. (Shanghai, China). NPC cells were seeded into 6-well plates and cultured with complete medium without antibiotics at least 24 h prior to transfection. Then, cells were transiently transfected with siRNAs, miRNAs, or pcDNAs, or cotransfected with si-XIST and anti-miR-29c or anti-miR-con using Lipofectamine™ 2000 (Invitrogen). The cells were harvested at different time points for analysis post-transfection.
+ Open protocol
+ Expand
6

Investigating miR-194 and NEAT1 in Osteosarcoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
The scrambled control miR (miR-con), miR-194 mimics (UGUA ACAGCAACUCCAUGUGGA), scrambled control anti-miR (anti-miR-con), and anti-miR-194 (UCCACAUGGAGUUGCU GUUACA) were synthesized by Genepharma (Shanghai, China). NEAT1 (GenBank #EF177379.1) was amplified from the cDNA of MG63 and U2OS cells and cloned into the pcDNA3.1 plasmid, which was named pcDNA-NEAT1. The siRNA sequence targeting NEAT1 was 5′-GUGAGAAGUUGCUUAGAAACUU UCC-3′ (si-NEAT1). si-NEAT1 and negative control siRNA (sicon) were obtained from GenePharma. Cells were transfected with plasmid or nucleotide sequences using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions.
+ Open protocol
+ Expand
7

Investigating circVAPA and CREB5 roles

Check if the same lab product or an alternative is used in the 5 most similar protocols
CircVAPA small interfering RNA (si-circVAPA), si-CREB5 and their negative control (si-con), miR-125a mimics (miR-125a), miR-125a inhibitor (anti-miR-125a) and their negative controls (miR-con and anti-miR-con) were provided by GenePharma (Shanghai, China). Moreover, pcDNA3.1-circVAPA (circVAPA), pcDNA3.1-CREB5 (CREB5) and pcDNA 3.1 empty vector (vector) were obtained from Genecreat (Wuhan, China). The oligonucleotide and vector were transfected in HCT116 and LOVO cells using Lipofectamine 3000 reagents (Invitrogen)based on the instruction guidelines.
+ Open protocol
+ Expand
8

Modulating SNHG12 and miR-148a in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
SNHG12 small interfering RNA and overexpression plasmid (si-SNHG12 and SNHG12) or their negative controls (si-con and pcDNA), miR-148a mimic and inhibitor (miR-148a and anti-miR-148a) or their negative controls (miR-con and anti-miR-con), CDK1 overexpression plasmid (CDK1) and its negative control (pcDNA) were designed and synthesized by GenePharma (Shanghai, China). Lentiviral short hairpin RNA targeting SNHG12 (sh-SNHG12) and its negative control (sh-con) were constructed by Genechem (Shanghai, China). Cells were transfected with indicated plasmids using Lipofectamine 3000 (Invitrogen).
+ Open protocol
+ Expand
9

Investigating miR-195 and OSBP in Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human SW872 and 93T449 cells (American Type Culture Collection, ATCC, Manassas, VA, USA) were grown in Dulbecco’s Modified Eagle Medium (Gibco, Carlsbad, CA, USA) containing 10% fetal bovine serum and 1% antibiotics (TaKaRa, Dalian, China). All cells were maintained in a 37°C, 5% CO2 incubator. miR-195 (GenePharma, Shanghai, China), and its corresponding scrambled oligonucleotide sequence (miR-con, GenePharma), anti-miR-195 (GenePharma) and its corresponding scrambled oligonucleotide sequence (anti-miR-con, GenePharma) were transfected into cells using Dharma FECT 4 transfection reagent (Dharmacon, Brebières, France), referring to the protocols of manufacturers. The full sequences of OSBP were inserted into the pcDNA vector (Promega, Southampton, UK) to construct OSBP overexpression plasmid (OSBP), and nontarget vector (pcDNA) was used as a negative control.
+ Open protocol
+ Expand
10

Podocyte Stress Response to High Glucose

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice podocytes were obtained from BeNa Culture Collection (BNCC, Suzhou, China) and cultured in RPMI-1640 medium (Gibco, Grand Island, NY, USA) containing 10% fetal bovine serum (Gibco), 100 U/mL penicillin and 0.1 mg/mL streptomycin at 37°C in 5% CO2. Meanwhile, different concentrations (0, 10, 20, 30 and 40 mM) of HG were used to treat the podocytes at different times (0, 12, 24 and 48 h) to determine the gene expression pattern and confirm the optimal concentration and time. A miR-203-3p mimic and inhibitor (miR-203-3p and anti-miR-203-3p) or their negative controls (miR-con and anti-miR-con), as well as a Semaphorin 3A (Sema3A) overexpression plasmid and its negative control (pcDNA) were synthesized by GenePharma (Shanghai, China). All plasmid oligonucleotides were transfected into podocytes using Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!